A 57 year-old gentleman with Waldenstrom's disease developed ecthyma gangrenosum, molluscum contagiosum and fatal cerebral toxoplasmosis. The emergence of these infections is discussed in the light of drug-induced immune-suppression.
ChesonBD.Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol1995: 13: 2431–2448.
2.
PescovitzMD.Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant2006; 6: 859–866.
3.
DredgeK, MarriottJB, DalgleishAG.Immunological effects of thalidomide and its chemical and functional analogs. Crit Rev Immunol2002; 22: 425–437.
4.
BullenJJ, RogersHJ, SpaldingPB, WardCG.Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol2006; 55: 251–258.
5.
SokolPA, WoodsDE.Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol1984; 18: 125–133.
6.
NgW, TanCL, YeowV, YeoM, TeoSH.Ecthyma gangrenosum in a patient with hypogammaglobulinemia. J Infect1998; 36: 331–335.
7.
El BazeP, ThyssA, VintiH.A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol1991; 71: 411–415.
8.
FergieJE, PatrickCP, LottL.Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children. Pediatr Infect Dis J1991; 10: 496–500.
9.
BoisseauAM, SarlangueJ, PerelY.Perineal ecthyma gangrenosum in infancy and early childhood: Septicemic and nonsepticemic forms. J Am Acad Dermatol1992; 27: 415–418.
10.
TropeBM, LenziME.AIDS and HIV infections: uncommon presentations. Clin Dermatol2005; 23: 572–580.
11.
ArendtG, von GiesenHJ, HefterH.Long-term course and outcome in AIDS patients with cerebral toxoplasmosis. Acta Neurol Scand1999; 100: 178–184.
12.
HoltkampM, OkuducuAF, KlingebielR, PlonerCJ.Cerebral toxoplasmosis in a patient with common variable immunodeficiency. Neurology2004; 63: 2192–2193.
13.
MashalyR, GrayF, PoissonM, RancurelG, EscourolleR, BugeA.Acquired cerebral toxoplasmosis in adults. Clinical and neuropathologic study. Rev Neurol (Paris)1983; 139: 561–568.
